Departments of Pharmacology, Capital Medical University, Beijing, China.
Acta Pharmacol Sin. 2009 Dec;30(12):1585-93. doi: 10.1038/aps.2009.160.
It is unclear why alpha(1D)-adrenergic receptors (alpha(1D)-ARs) play a critical role in the mediation of peripheral vascular resistance and blood pressure in situ but function inefficiently when studied in vitro. The present study examined the causes for these inconsistencies in native alpha(1)-adrenergic functional performance between the vascular smooth muscle and myocytes.
The alpha(1)-adrenergic mediated contraction, Ca(2+) signaling and the subcellular receptor distribution were evaluated using the Fluo-4, BODIPY-FL prazosin and subtype-specific antibodies.
Rat aortic rings and freshly dissociated myocytes displayed contractile and increased intracellular Ca(2+) responses to stimulation with phenylephrine (PE, 10 micromol), respectively. However, the PE-induced responses disappeared completely in cultured aortic myocytes, whereas PE-enhanced Ca(2+) transients were seen in cultured rat cardiac myocytes. Further studies indicated that alpha(1D)-ARs, the major receptor subtype responsible for the alpha(1)-adrenergic regulation of aortic contraction, were distributed both intracellularly and at the cell membrane in freshly dispersed aortic myocytes, similar to the alpha(1A)-AR subcellular localization in the cultured cardiomyocytes. In the cultured aortic myocytes, however, in addition to a marked decrease in their protein expression relative to the aorta, most labeling signals for alpha(1D)-ARs were found in the cytoplasm. Importantly, treating the culture medium with charcoal/dextran caused the reappearance of alpha(1D)-ARs at the cell surface and a partial restoration of the Ca(2+) signal response to PE in approximately 30% of the cultured cells.
Reduction in alpha(1D)-AR total protein expression and disappearance from the cell surface contribute to the insensitivity of cultured vascular smooth muscle cells to alpha(1)-adrenergic receptor activation.
尚不清楚为什么α1D-肾上腺素能受体(α1D-AR)在体内介导外周血管阻力和血压方面起着关键作用,但在体外研究时其功能效率低下。本研究旨在探讨在血管平滑肌和心肌细胞中,α1-肾上腺素能功能表现存在这种固有差异的原因。
使用 Fluo-4、BODIPY-FL 哌唑嗪和亚型特异性抗体评估α1-肾上腺素能介导的收缩、Ca2+信号和亚细胞受体分布。
大鼠主动脉环和新鲜分离的心肌细胞分别对苯肾上腺素(PE,10μmol)刺激表现出收缩和细胞内 Ca2+反应增加。然而,在培养的主动脉心肌细胞中,PE 诱导的反应完全消失,而在培养的大鼠心肌细胞中观察到 PE 增强的 Ca2+瞬变。进一步的研究表明,α1D-AR,是负责调节主动脉收缩的主要受体亚型,在新鲜分散的主动脉心肌细胞中分布在细胞内和细胞膜上,类似于培养的心肌细胞中α1A-AR 的亚细胞定位。然而,在培养的主动脉心肌细胞中,除了其蛋白表达相对于主动脉明显减少之外,大多数α1D-AR 标记信号都存在于细胞质中。重要的是,用活性炭/葡聚糖处理培养基会导致α1D-AR 重新出现在细胞表面,并使大约 30%的培养细胞中对 PE 的 Ca2+信号反应部分恢复。
α1D-AR 总蛋白表达的减少和从细胞表面消失导致培养的血管平滑肌细胞对α1-肾上腺素能受体激活不敏感。